Identification and treatment of cervical and oromandibular dystonia in acutely brain-injured patients

Neurocritical Care

Volumn 3, Issue 2, 2005, Pages 139-145

  Lo, Steven E ^a   Rosengart, Axel J ^a,b   Novakovic, Roberta L ^a   Un, Jung Kang ^a   Shah, Darshan N ^a   Khan, Mohsin A ^a   Dalvi, Arif ^a   Goldenberg, Fernando D ^a,b   Macdonald, R Loch ^b   Frank, Jeffrey I ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Botulinum toxin; Brain injury; Cervical dystonia; Intracerebral hemorrhage; Oromandibular dystonia

Indexed keywords

BOTULINUM TOXIN A;

ARTICLE; BRAIN HEMORRHAGE; BRAIN INJURY; CEREBROVASCULAR ACCIDENT; CERVICAL DYSTONIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; DISEASE ASSOCIATION; DYSPHAGIA; DYSTONIA; EPILEPTIC STATE; HUMAN; INJECTION SITE REACTION; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MUSCLE WEAKNESS; ONSET AGE; OROMANDIBULAR DYSTONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCREENING; TREATMENT OUTCOME;

ADULT; ANTI-DYSKINESIA AGENTS; BOTULINUM TOXINS; BRAIN INJURIES; CHILD, PRESCHOOL; CRITICAL CARE; DYSTONIC DISORDERS; FEMALE; HUMANS; MALE; MANDIBULAR DISEASES; MIDDLE AGED; MOUTH DISEASES; POSTURE; TORTICOLLIS; TREATMENT OUTCOME;

EID: 24944483056     PISSN: 15416933     EISSN: None     Source Type: Journal    
DOI: 10.1385/NCC:3:2:139     Document Type: Article

References (33)

1. Dauer WT, Burke RE, Greene P, Fahn S. Current concepts on the clinical features, aetiology and management of idiopathic cervical dystonia. Brain 1998;121:547-560.
2. Stacy M. Idiopathic cervical dystonia: an overview. Neurology 2000;12(Suppl 5):S2-S8.
3. Jankovic J. Etiology and differential diagnosis of blepharospasm and oromandibular dystonia. Adv Neurol 1988;49:103-116.
4. Fahn S, Marsden CD, Calne DB. Classification and investigation of dystonia. In: Marsden CD, Fahn S, eds. Movement disorders 2. London: Butterworth, 1987:332-358.
5. Adler CH. Cervical, oromandibular and laryngeal dystonias. In: Adler CH, ed. Botulinum toxins: practical issues and clinical uses for neurologists. Education Program Syllabus, AAN 56th Annual Meeting. 2004:3PC-004-31-004-36.
6. Comella CL, Pullman SL. Botulinum toxins in neurological disease. Muscle Nerve 2004;29:628-644.
7. Ondo WG, Vuong KD, Derman HS. Botulinum toxin A for chronic daily headache: a randomized, placebo-controlled, parallel design study. Cephalalgia 2004;24:60-65.
8. Miscio G, Del Conte C, Pianca D, et al. Botulinum toxin in post-stroke patients: stiffness modifications and clinical implications. J Neurol 2004; 251,189-196.
9. Naumann M, Eberhardt B, Laskawi R, et al. Botulinum toxin in rare pain syndromes. J Neurol 2004;251(Suppl 1):I39-I40.
10. Royal MA. Botulinum toxins in pain management. Phys Med Rehabil Clin N Am 2003;14:805-820.
11. LeDoux MS, Brady KA. Secondary cervical dystonia associated with structural lesions of the central nervous system. Mov Disord 2003;18:60-69.
12. Kwak CH, Jankovic J. Tourettism and dystonia after subcortical stroke. Mov Disord 2002;17:821-825.
13. Molho ES, Factor, SA. Basal ganglia infarction as a possible cause of cervical dystonia. Mov Disord 1993;8:213-216.
14. Schwartz M, De Deyn PP, Van de kerchove M, Pickut BA. Cervical dystonia as a probable consequence of focal cerebral lesion. Mov Disord 1995;10:797-798.
15. Factor SA, Troche-Panetto M, Weaver SA. Dystonia in AIDS: report of four cases. Mov Disord 2003;18:1492-1498.
16. Biary N, Al Deeb SM, Aabed M. Post-traumatic dystonia. Ann Neurol 1991;30:297.
17. Maki Y, Akimoto H, Enomoto T. Injuries of basal ganglia following head trauma in children. Child's Brain 1980;7:113-123.
18. Brans JW, Lindeboom R, Snoek JW, et al. Botulinum toxin versus trihexyphenidyl in cervical dystonia: a prospective, randomized, double-blind controlled trial. Neurology 1996;46:1066-1072.
19. Lo SE, Rosengart AJ, Frank JI, et al. Cranial dystonia in patients with acute brain injury: a demographic study and a pilot trial using botulinum toxin. Neurology 2004;62 (Suppl 5):A368.
20. Comella CL, Stebbins GT, Goetz CG, Chmura TA, Bressman SB, Lang AE. Teaching tape for the motor section of the Toronto Western Spasmodic Torticollis Scale. Mov Disord 1997;12:570-575.
21. Tarsy D. Comparison of clinical rating scales in treatment of cervical dystonia with botulinum toxin. Mov Disord 1997;12:100-102.
22. Marsden CD, Obeso JA, Zarranz JJ, Lang AE. The anatomical basis of symptomatic hemidystonia. Brain 1985;108:463-483.
23. Schulze-Bonhage A, Ferbert A. Cervical dystonia as an isolated sign of a basal ganglia tumor. J Neurol Neurosurg Psychiatry 1995;58:108-109.
24. Soland V, Evoy F, Rivest J. Cervical dystonia due to a frontal meningioma. Mov Disord 1996;11:336-337.
25. Baquis GD, Rosman NP. Pressure-related torticollis: an unusual manifestation of pseudotumor cerebri. Pediatr Neurol 1989;5:111-113.
26. Straussberg R, Harel L, Amir J. Pseudotumor cerebri manifesting as stiff neck and torticollis. Pediatr Neurol 2002;26:225-227.
27. Kajimoto Y, Miwa H, Ueno M, Kondo T. Sensorimotor hemiparesis with secondary cervical dystonia following lateral caudal medullary infarction without signs and symptoms of Wallenberg syndrome. J Neurol Sci 2004;219:167-168.
28. Jacob PC, Chand PR. Blepharospasm and jaw closing dystonia after parietal infarcts. Mov Disord 1995;10:794-802.
29. Krauss JK, Mohadjer M, Braus DF, Wakhloo AK, Nobbe F, Mundinger F. Dystonia following head trauma: a report of nine patients and review of the literature. Mov Disord 1992;7:263-272.
30. Tarsy D. Comparison of acute- and delayed-onset posttraumatic cervical dystonia. Mov Disord 1998;13:481-485.
31. Isaac KI, Cohen JA. Post-traumatic torticollis. Neurology 1989;39:1642-1643.
32. Bhatia KP, Marsden CD. The behavioral and motor consequences of focal lesions of the basal ganglia in man. Brain 1994;117:859-876.
33. Lee MS, Marsden CD. Movement disorders following lesions of the thalamus or subthalamic region. Mov Disord 1994;9:493-507.